Ken Song

Summary

Publications

  1. pmc Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population
    Ken Song
    Ariosa Diagnostics, Inc, San Jose, CA, USA
    J Matern Fetal Neonatal Med 26:1180-5. 2013
  2. doi request reprint Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18
    Andrew B Sparks
    Aria Diagnostics, San Jose, CA 95138, USA
    Am J Obstet Gynecol 206:319.e1-9. 2012
  3. doi request reprint Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma
    Eric Wang
    Ariosa Diagnostics, San Jose, CA, USA
    Prenat Diagn 33:662-6. 2013
  4. doi request reprint Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice
    Thomas J Musci
    Ariosa Diagnostics Inc, San Jose, CA, USA
    Prenat Diagn 33:424-8. 2013
  5. ncbi request reprint Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis
    Craig A Struble
    Ariosa Diagnostics, Inc, San Jose, Calif, USA
    Fetal Diagn Ther 35:199-203. 2014
  6. pmc Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy
    Andrew B Sparks
    Aria Diagnostics Inc, 5945 Optical Court, San Jose, CA 95138, USA
    Prenat Diagn 32:3-9. 2012

Collaborators

  • Thomas J Musci
  • Kypros H Nicolaides
  • Aaron B Caughey
  • Eric Wang
  • Craig A Struble
  • Andrew B Sparks
  • Arnold Oliphant
  • Argyro Syngelaki
  • Patrick Pattee
  • Jill Garrison
  • Naiping Shen
  • Aoy Tomita-Mitchell
  • Desiree Hollemon
  • Celeste McBride
  • Jay Sandler
  • Wade Barrett
  • Michael Mitchell
  • Renee Stokowski
  • Michel Sun
  • Kevin Lee
  • Jigna Doshi
  • Jacob Zahn
  • John Stuelpnagel

Detail Information

Publications6

  1. pmc Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population
    Ken Song
    Ariosa Diagnostics, Inc, San Jose, CA, USA
    J Matern Fetal Neonatal Med 26:1180-5. 2013
    ..Evaluate the clinical and economic consequences of fetal trisomy 21 (T21) screening with non-invasive prenatal testing (NIPT) in high-risk pregnant women...
  2. doi request reprint Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18
    Andrew B Sparks
    Aria Diagnostics, San Jose, CA 95138, USA
    Am J Obstet Gynecol 206:319.e1-9. 2012
    ..We sought to develop a novel biochemical assay and algorithm for the prenatal evaluation of risk for fetal trisomy 21 (T21) and trisomy 18 (T18) using cell-free DNA obtained from maternal blood...
  3. doi request reprint Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma
    Eric Wang
    Ariosa Diagnostics, San Jose, CA, USA
    Prenat Diagn 33:662-6. 2013
    ..To determine the effects of gestational age and maternal weight on percent fetal cell-free DNA (cfDNA) in maternal plasma and the change in fetal cfDNA amounts within the same patient over time...
  4. doi request reprint Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice
    Thomas J Musci
    Ariosa Diagnostics Inc, San Jose, CA, USA
    Prenat Diagn 33:424-8. 2013
    ..The aim of this study was to assess awareness, potential adoption, and current utilization of non-invasive prenatal testing (NIPT) analysis for common fetal aneuploidies among obstetricians...
  5. ncbi request reprint Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis
    Craig A Struble
    Ariosa Diagnostics, Inc, San Jose, Calif, USA
    Fetal Diagn Ther 35:199-203. 2014
    ..This involves estimation of total FF in monozygotic twins and estimation of the lower FF of the 2 fetuses in dizygotic twins. © 2013 S. Karger AG, Basel. ..
  6. pmc Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy
    Andrew B Sparks
    Aria Diagnostics Inc, 5945 Optical Court, San Jose, CA 95138, USA
    Prenat Diagn 32:3-9. 2012
    ..To develop a novel prenatal assay based on selective analysis of cell-free DNA in maternal blood for evaluation of fetal Trisomy 21 (T21) and Trisomy 18 (T18)...